SOL Group: update on the investigation towards VIVISOL S.r.l.
February 13, 2023 at 11:08 am EST
Share
per
COMUNICATO STAMPA
SOL Group: update on the investigation towards VIVISOL S.r.l..
With reference to the previous press releases dated 22 October 2022 and 3 November 2022, we inform you that, on 10 February 2023, following a specific and justified request presented by the company Vivisol S.r.l. and with the favourable opinion of the Public Prosecutor, the Preliminary Investigation Judge of the Court of Palermo revoked with immediate effect the provisional precautionary measure of the ban on contracting with the Public Administration, a measure which had been imposed on Vivisol and which had already been suspended last November 2, 2022.
The revocation eliminates any remaining obstacle to the full operation of Vivisol S.r.l. which confirms its complete trust in the Judiciary, certain that its extraneousness to the disputed will emerge from the continuation of the investigations.
SOL is an Italian multinational Group that operates in Europe, Turkey, Morocco, Brazil, India and China in two distinct main sectors: the production, applied research and marketing of technical, pure and medicinal gases (Technical Gases Division) and the Home Care Division.
Contacts:
Barabino & Partners
Marina Riva
Phone +39 02 72 02 35 35
m.riva@barabino.it
Monza, 13 February, 2023
Attachments
Original Link
Original Document
Permalink
Disclaimer
SOL S.p.A. published this content on 13 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 February 2023 16:07:05 UTC.
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Companyâs product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
SOL S.P.A. 
